Clinical trials
Tuberculosis, Pulmonary clinical trials
Below are recruiting tuberculosis, pulmonary clinical trials, each written for real people, not researchers. We’re tracking 45 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07077213Recruiting
PET scan test for TB-related lung scarring
This study uses a special PET scan (called FAPI-74) to see if it can detect fibrosis (scarring) in the lungs of people with active TB. It looks at the scan both at the start of treatment and after 6 months of therapy to understand how the lungs heal.
Cincinnati, OhioAges 18 years+ - NCT06403943RecruitingPhase 4
Chinese herbs with standard TB treatment for lung health
This trial tests if adding a Chinese herbal formula (BaiDiZiYin ShenQiYiFei) to standard tuberculosis drugs helps improve symptoms like shortness of breath, fatigue, and coughing. It may be helpful for people diagnosed with pulmonary TB who also have signs of Qi and Yin deficiency (a traditional Chinese medicine pattern).
Beijing, Beijing MunicipalityAges 18–65 - NCT04147286RecruitingPhase 2/Phase 3
Atorvastatin to lower lingering inflammation after TB treatment
This trial studies whether atorvastatin (a cholesterol medicine) can reduce ongoing inflammation after you finish standard tuberculosis (TB) treatment. If it works, it may improve how your body recovers after TB, especially by lowering inflammation-related signals.
Observatory, WCAges 18–65 - NCT05539014Recruiting
Study of newly diagnosed tuberculosis patients at Avicenne Hospital
This study follows people who are newly treated for tuberculosis, including lung and non-lung (extra-lung) cases. It may help doctors better understand tuberculosis and how patients respond after treatment starts.
BobignyAges 18–80 - NCT06526221Enrolling by invitation
Urine test to check TB medication use
This study checks a simple urine test to see if people with TB are taking their medication (isoniazid) regularly. It aims to help doctors find out sooner if someone is missing doses, so they can offer extra support.
Chennai, Tamil NaduAges 18 years+ - NCT06714513RecruitingPhase 1
TB vaccine study in older adults aged 55 to 74
This study tests a new tuberculosis (TB) vaccine (ID93+GLA-SE) in healthy adults aged 55 to 74. It aims to see if the vaccine is safe and can help protect against TB, especially in people who may have latent (inactive) TB infection.
Gwangmyeong, Gyeonggi-doAges 55–74 - NCT06727864RecruitingPhase 3
Short-course treatment for low-risk active lung TB
This trial tests a shorter treatment course (instead of the standard 6 months) for people with low-risk active TB in the lungs. It aims to see if the shorter regimen works just as well and has fewer side effects.
New Taipei City, BangiaoAges 20–99 - NCT06477185RecruitingPhase 2
Preventing lung scarring after TB with doxycycline
This trial tests whether the antibiotic doxycycline can prevent lung scarring (fibrosis) after a serious TB infection. You may be eligible if you are currently being treated for active TB and have significant lung damage on your chest X-ray.
Kampala, KampalaAges 18–65 - NCT07387601Recruiting
Peer education for TB treatment in Ethiopia
This trial tests whether having a peer educator (someone who has been through TB treatment) help you stay on track with your medicines and get better. It is for adults with new, easy-to-treat TB in South Omo and Ari Zone, Ethiopia.
Jinka, Southern EthiopiaAges 18 years+ - NCT07313995Recruiting
Digital health tool to help people take TB prevention
This study tests whether a digital health tool can help more people start and complete tuberculosis preventive treatment (TPT). If you live with or have close contact with someone who has drug-sensitive TB and live in the area for at least 4 months, you may be able to join.
Arba Minch, South EthiopiaAges Any age - NCT06057519RecruitingPhase 3
Optimized rifampicin dosing for TB
This trial tests whether higher or standard doses of the antibiotic rifampicin work better for treating pulmonary tuberculosis (a lung infection). You may benefit if you are starting TB treatment and have not had a bad reaction to rifampicin before.
TurinAges 18 years+ - NCT06114628RecruitingPhase 2
Finding the best treatment for lung TB (PARADIGM4TB)
This study tests different ways to treat active lung TB that is not resistant to rifampicin. It aims to find the best treatment duration and combination to cure TB and prevent it from coming back.
ChisinauAges 18 years+ - NCT06905522RecruitingPhase 3
Tuberculosis treatment trial for new patients
This trial tests a combination of drugs for people with active tuberculosis who have not been treated before. It aims to find a better way to treat TB, even if the bacteria are resistant to some drugs.
BeijingAges 18–65 - NCT07073638RecruitingPhase 2
Testing a new TB drug called RESP30TB in people with newly diagnosed TB
This trial tests a new drug, RESP30TB, to see if it is safe, tolerable, and can quickly kill TB bacteria in people with newly diagnosed, rifampicin-susceptible pulmonary TB. You may be eligible if you can produce sputum and meet other health criteria.
Cape Town, BellvilleAges 18–65 - NCT07271225Recruiting
Ear acupuncture for nausea from TB drugs
This study tests whether ear acupuncture can help reduce nausea and vomiting caused by tuberculosis medications. It is for people who are at least 17 years old, have drug-sensitive or certain types of drug-resistant TB, and feel sick after taking their TB pills.
Jakarta, Jakarta TimurAges 17 years+ - NCT06744179Enrolling by invitation
Post-TB Sequelae Study: How the body heals after TB
This study looks at how the body recovers from tuberculosis (TB). It compares people who have had TB to those who have not, to understand long-term health effects. Participants will be asked to come for follow-up visits in Dhaka.
Dhaka, Dhaka DivisionAges 6 months+ - NCT05426720Recruiting
Looking for TB lung damage risk factors and blood markers
This study looks at what increases the risk of long-term lung damage after active pulmonary tuberculosis (TB). It also tests whether certain blood or other markers can predict who is more likely to have lung problems later.
BeijingAges 25–60 - NCT02354014RecruitingPhase 2
Test drug levels and TB activity of TMC207 in children
This study measures how TMC207 (an anti-TB medicine) works in the body and in combination with standard MDR-TB medicines for children and teens with lung MDR-TB. It may help clinicians learn the safest way to use TMC207 and how well it may support treatment.
MaputoAges birth–18 years - NCT02527486Recruiting
Airways registry study for people with COPD symptoms
This registry collects information from people with COPD (and sometimes overlapping asthma-COPD features) to better understand breathing problems and airways behavior. It may help researchers learn which patterns match different symptom types, without necessarily using a new drug.
Seongnam-si, Gyeonggi-doAges 20–90 - NCT07164742Recruiting
Recovery help for lung health after TB treatment
This study tests whether a lung rehabilitation program (like physical therapy for your lungs) can help people who recently started TB treatment breathe and feel better. You need a smartphone and must be willing to attend sessions for 48 weeks.
MangaloreAges 18 years+ - NCT06262282Enrolling by invitation
Phage therapy for stubborn NTM infection in cystic fibrosis
This trial tests whether a special virus therapy (phage) can help clear stubborn NTM lung infections in people with cystic fibrosis who have been on antibiotics for over a year without success. Participants will continue their antibiotics while receiving the phages.
Birmingham, AlabamaAges 6 years+
Hear when a new Tuberculosis, Pulmonary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for tuberculosis, pulmonary?
- Yes. Clin2 currently lists 45 recruiting tuberculosis, pulmonary studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a tuberculosis, pulmonary trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a tuberculosis, pulmonary trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.